BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 8061014)

  • 1. Cytomegalovirus after heart transplantation. Risk factors for infection and death: a multiinstitutional study. The Cardiac Transplant Research Database Group.
    Kirklin JK; Naftel DC; Levine TB; Bourge RC; Pelletier GB; O'Donnell J; Miller LW; Pritzker MR
    J Heart Lung Transplant; 1994; 13(3):394-404. PubMed ID: 8061014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group.
    Schowengerdt KO; Naftel DC; Seib PM; Pearce FB; Addonizio LJ; Kirklin JK; Morrow WR
    J Heart Lung Transplant; 1997 Dec; 16(12):1207-16. PubMed ID: 9436132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection after heart transplantation: a multiinstitutional study. Cardiac Transplant Research Database Group.
    Miller LW; Naftel DC; Bourge RC; Kirklin JK; Brozena SC; Jarcho J; Hobbs RE; Mills RM
    J Heart Lung Transplant; 1994; 13(3):381-92; discussion 393. PubMed ID: 8061013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: a multivariable, multiinstitutional report. The Cardiac Transplant Research Database Group.
    Young JB; Naftel DC; Bourge RC; Kirklin JK; Clemson BS; Porter CB; Rodeheffer RJ; Kenzora JL
    J Heart Lung Transplant; 1994; 13(3):353-64; discussion 364-5. PubMed ID: 8061010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group.
    Bourge RC; Naftel DC; Costanzo-Nordin MR; Kirklin JK; Young JB; Kubo SH; Olivari MT; Kasper EK
    J Heart Lung Transplant; 1993; 12(4):549-62. PubMed ID: 8369318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does cytomegalovirus serology impact outcome after pediatric heart transplantation?
    Mahle WT; Fourshee MT; Naftel DM; Alejos JC; Caldwell RL; Uzark K; Berg A; Kanter KR;
    J Heart Lung Transplant; 2009 Dec; 28(12):1299-305. PubMed ID: 19783178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for late recurrent rejection after heart transplantation: a multiinstitutional, multivariable analysis. Cardiac Transplant Research Database Group.
    Kubo SH; Naftel DC; Mills RM; O'Donnell J; Rodeheffer RJ; Cintron GB; Kenzora JL; Bourge RC; Kirklin JK
    J Heart Lung Transplant; 1995; 14(3):409-18. PubMed ID: 7654724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. The Pediatric Heart Transplantation Study Group.
    Morrow WR; Naftel D; Chinnock R; Canter C; Boucek M; Zales V; McGiffin DC; Kirklin JK
    J Heart Lung Transplant; 1997 Dec; 16(12):1255-66. PubMed ID: 9436138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
    Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heart transplantation 1985-1995: 10 years experience at the "Angelo De Gasperis" center. Improvement of results by progress in operative criteria].
    Colombo T; Borrello B; Lanfranconi M; Pomé G; Quaini E; Russo C; Vitali E; Grassi M; Frigerio M; Gronda E; Mangiavacchi M; Merli M; Pellegrini A
    G Ital Cardiol; 1997 Jan; 27(1):3-18. PubMed ID: 9244710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart transplantation 1985-1998: 13-years experience at Angelo De Gasperis Cardio-Thoracic Department-Milan.
    Colombo T; Vitali E; Lanfranconi M; Russo C; Bruschi G; Marchetti C; Colucci V; Frigerio M; Oliva F; Grassi M; Gronda E; Merli M; Pellegrini A
    Clin Transpl; 1998; ():315-25. PubMed ID: 10503110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function.
    Petrakopoulou P; Kübrich M; Pehlivanli S; Meiser B; Reichart B; von Scheidt W; Weis M
    Circulation; 2004 Sep; 110(11 Suppl 1):II207-12. PubMed ID: 15364864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplantation risk factors for acute rejection after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group.
    Kobashigawa JA; Kirklin JK; Naftel DC; Bourge RC; Ventura HO; Mohanty PK; Cintron GB; Bhat G
    J Heart Lung Transplant; 1993; 12(3):355-66. PubMed ID: 8329404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
    Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
    Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic determinants of six-month morbidity and mortality in heart transplant recipients. The Italian Study Group on Infection in Heart Transplantation.
    De Maria R; Minoli L; Parolini M; Gavazzeni G; Gentile M; Grossi P; Livi U; Parisi F; Utili R
    J Heart Lung Transplant; 1996 Feb; 15(2):124-35. PubMed ID: 8672515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMV infections following allogeneic BMT: risk factors, early treatment and correlation with transplant related mortality.
    Bacigalupo A; Tedone E; Sanna MA; Moro F; Van Lint MT; Grazi G; Balestreri M; Frassoni F; Occhini D; Gualandi F
    Haematologica; 1992; 77(6):507-13. PubMed ID: 1337746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redo lung transplantation: a North American-European experience.
    Novick RJ; Kaye MP; Patterson GA; Andréassian B; Klepetko W; Menkis AH; McKenzie FN
    J Heart Lung Transplant; 1993; 12(1 Pt 1):5-15; discussion 15-6. PubMed ID: 8382951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
    Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.